The Next Era of Gene Editing Will Be Disease Agnostic
At the WIRED Health summit last week, Harvard biochemist and gene-editing pioneer David Liu says later this year his lab plans to report on a single gene-editing strategy that could treat many unrelated diseases. He calls it disease-agnostic therapeutic gene editing. “It sounds sort of crazy, but there’s actually a very good molecular biology reason why this could be possible,” he told the audience in Boston, stopping short of details. Gene-editing treatments are currently being developed for